Meet the MiSeq i100 Series – the new standard in sequencing simplicity with a 3-step setup, onboard DRAGEN analysis, and same-day results to accelerate genomic discovery and insights: https://bit.ly/4eTqugz
Illumina
Biotechnology Research
San Diego, CA 489,201 followers
Unlocking the Power of the Genome
About us
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
- Website
-
http://www.illumina.com
External link for Illumina
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- San Diego, CA
- Type
- Public Company
- Founded
- 1998
Products
BaseSpace Clarity LIMS
Laboratory Information Management Systems (LIMS)
BaseSpace Clarity LIMS is a laboratory information management system that helps genomics labs track samples and manage workflows for an optimized and efficient lab.
Locations
Employees at Illumina
Updates
-
Today we revealed our newest product to make sequencing simple — the MiSeq i100 Series. Julianna LeMieux at Genetic Engineering & Biotechnology News reported in depth about our journey to bring faster run times and room temperature reagent storage to every lab, everywhere.
-
The wait is almost over...join us tomorrow as we take sequencing to the next-level. Register now: https://bit.ly/3zCV0fG
-
Space technology 🤝 forest conservation. Discover how NASA's Global Ecosystem Dynamics Investigation sensor (GEDI) aboard the International Space Station is using lasers to map forest health from space, while genetic sequencing on Earth provides insight into tree resilience against threats like drought and disease. In partnership with the University of Notre Dame, Professor Nathan Swenson, his students and NASA - National Aeronautics and Space Administration, we're helping scientists monitor ecosystems like never before. #IlluminaProud #NASA Explore the full story: https://bit.ly/3MQCWll
-
Cerebral palsy (CP) is the most common motor disability in children, occurring in 1.5 to 2.5 of every 1000 live births worldwide. On World Cerebral Palsy Day, we recognize the important work being done by the Australian Collaborative Cerebral Palsy Research Group at the University of Adelaide. Their team has amassed genomic and associated metadata on nearly 600 people with CP and their parents, striving to help enable early intervention and tailored therapies. Learn more: https://bit.ly/3BtXCgh #WorldCerebralPalsyDay
Research reveals considerable genetic origin for unselected cerebral palsy
illumina.com
-
Something revolutionary is on the horizon – and it’s smaller than you think. Be among the first to witness this high-impact breakthrough at our virtual event on October 9. Secure your spot: https://bit.ly/3zCV0fG
-
“Genomic testing saved my life.” At just 25, Chris Ollis was diagnosed with Stage IV myopericytoma, a rare and aggressive cancer. Told he had just two years to live, his options were limited—until genomic testing uncovered a gene fusion. That discovery opened the door to a clinical trial that would change everything. Nine years later, Chris is a proud husband and father of four, living life to the fullest. Find out how genomic testing changed his journey: https://bit.ly/3ZT6ZQT
-
In an inspiring all-night relay, the Singapore team raised funds for the Singapore Cancer Society as part of their ongoing commitment to making a difference in patient support and cancer research. Learn about their efforts to give back: https://bit.ly/4gPgMO8
-
How does next-generation sequencing compare to traditional methods like Sanger sequencing and qPCR? Let's break it down. https://bit.ly/3WUKWq6
-
The next big thing in sequencing is coming. And it’s small. Learn more at our virtual event on October 9 at 9 a.m. PT: https://bit.ly/3zCV0fG
Affiliated pages
Similar pages
Browse jobs
Stock
ILMN
NASDAQ
20 minutes delay
$145.54
1.78 (1.238%)
- Open
- 143.74
- Low
- 142.06
- High
- 145.94
Data from Refinitiv
See more info on